Matches in SemOpenAlex for { <https://semopenalex.org/work/W929161023> ?p ?o ?g. }
- W929161023 abstract "Antigen-presenting cells including dendritic cells (DCs) express mannan receptors (MR) on their surface, which can be exploited in cancer therapy by designing immune-stimulatory viruses coated with mannan-modified capsids that then bind to DCs and initiate a potent immune response. Although the combination of anti-angiogenesis and cancer immunotherapy agents has a synergistic antitumor effect, more effective strategies for delivering such combinations are still required. Here we report the design and application of mannan-modified adenovirus that expresses both telomerase reverse transcriptase (TERT) and vascular endothelial growth factor receptor-2 (VEGFR-2). Cytotoxic T lymphocytes that are reactive to TERT and VEGFR-2 are capable of mounting an anti-tumour response in murine breast and colon tumour models and in a lung metastatic model. Compared with mannan-modified TERT adenovirus vaccine or mannan-modified VEGFR-2 adenovirus vaccine alone, the combined vaccine showed remarkably synergistic anti-tumour immunity in these models. Both TERT- and VEGFR-2-specific cytotoxic T lymphocytes (CTL) were identified in an in vitro cytotoxicity assay, and the CTL activity against tumour cells was significantly elevated in the combined vaccine group. Furthermore, CTL-mediated toxicity was blocked by anti-CD8 monoclonal antibodies. Thus, the combined mannan-modified TERT and VEGFR-2 adenovirus confers potent anti-tumour immunity by targeting both tumour cells and intratumoural angiogenesis." @default.
- W929161023 created "2016-06-24" @default.
- W929161023 creator A5006292544 @default.
- W929161023 creator A5006882159 @default.
- W929161023 creator A5016477165 @default.
- W929161023 creator A5018283590 @default.
- W929161023 creator A5020937100 @default.
- W929161023 creator A5033153957 @default.
- W929161023 creator A5033856784 @default.
- W929161023 creator A5047160583 @default.
- W929161023 creator A5050463208 @default.
- W929161023 creator A5058006003 @default.
- W929161023 creator A5073501391 @default.
- W929161023 creator A5090403310 @default.
- W929161023 date "2015-06-18" @default.
- W929161023 modified "2023-09-23" @default.
- W929161023 title "Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine" @default.
- W929161023 cites W1493043780 @default.
- W929161023 cites W1516408312 @default.
- W929161023 cites W1585873539 @default.
- W929161023 cites W1637209605 @default.
- W929161023 cites W1679229092 @default.
- W929161023 cites W1894685526 @default.
- W929161023 cites W1960701436 @default.
- W929161023 cites W1967416824 @default.
- W929161023 cites W1971634709 @default.
- W929161023 cites W1973918329 @default.
- W929161023 cites W1976841472 @default.
- W929161023 cites W1977636829 @default.
- W929161023 cites W1978929016 @default.
- W929161023 cites W1980361000 @default.
- W929161023 cites W1981134411 @default.
- W929161023 cites W1984428739 @default.
- W929161023 cites W1984515783 @default.
- W929161023 cites W1986154258 @default.
- W929161023 cites W1996242613 @default.
- W929161023 cites W1997733598 @default.
- W929161023 cites W2000971601 @default.
- W929161023 cites W2008438789 @default.
- W929161023 cites W2008667095 @default.
- W929161023 cites W2009435076 @default.
- W929161023 cites W2013041233 @default.
- W929161023 cites W2015187541 @default.
- W929161023 cites W2020841140 @default.
- W929161023 cites W2024146490 @default.
- W929161023 cites W2035693645 @default.
- W929161023 cites W2042236580 @default.
- W929161023 cites W2044764392 @default.
- W929161023 cites W2056416920 @default.
- W929161023 cites W2062783581 @default.
- W929161023 cites W2066287087 @default.
- W929161023 cites W2069340283 @default.
- W929161023 cites W2073308580 @default.
- W929161023 cites W2073788351 @default.
- W929161023 cites W2075809315 @default.
- W929161023 cites W2076060212 @default.
- W929161023 cites W2079638377 @default.
- W929161023 cites W2090453278 @default.
- W929161023 cites W2091566003 @default.
- W929161023 cites W2094056217 @default.
- W929161023 cites W2095242372 @default.
- W929161023 cites W2100669312 @default.
- W929161023 cites W2102140960 @default.
- W929161023 cites W2103562758 @default.
- W929161023 cites W2106694587 @default.
- W929161023 cites W2115182182 @default.
- W929161023 cites W2115346781 @default.
- W929161023 cites W2128723862 @default.
- W929161023 cites W2137074525 @default.
- W929161023 cites W2141648783 @default.
- W929161023 cites W2142300779 @default.
- W929161023 cites W2145835533 @default.
- W929161023 cites W2146848549 @default.
- W929161023 cites W2157699006 @default.
- W929161023 cites W2157734449 @default.
- W929161023 cites W2157769714 @default.
- W929161023 cites W2242631542 @default.
- W929161023 cites W2313168486 @default.
- W929161023 cites W4235672273 @default.
- W929161023 doi "https://doi.org/10.1038/srep11275" @default.
- W929161023 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4471666" @default.
- W929161023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26085010" @default.
- W929161023 hasPublicationYear "2015" @default.
- W929161023 type Work @default.
- W929161023 sameAs 929161023 @default.
- W929161023 citedByCount "11" @default.
- W929161023 countsByYear W9291610232016 @default.
- W929161023 countsByYear W9291610232017 @default.
- W929161023 countsByYear W9291610232018 @default.
- W929161023 countsByYear W9291610232019 @default.
- W929161023 countsByYear W9291610232020 @default.
- W929161023 crossrefType "journal-article" @default.
- W929161023 hasAuthorship W929161023A5006292544 @default.
- W929161023 hasAuthorship W929161023A5006882159 @default.
- W929161023 hasAuthorship W929161023A5016477165 @default.
- W929161023 hasAuthorship W929161023A5018283590 @default.
- W929161023 hasAuthorship W929161023A5020937100 @default.
- W929161023 hasAuthorship W929161023A5033153957 @default.
- W929161023 hasAuthorship W929161023A5033856784 @default.
- W929161023 hasAuthorship W929161023A5047160583 @default.